A real world study analysing effectiveness of BNT162b2 and ChAdOx1-S vaccines against confirmed covid-19 symptoms
Latest Information Update: 20 May 2021
At a glance
- Drugs AZD 1222 (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 20 May 2021 Results published in the British Medical Journal
- 20 May 2021 New trial record